February 10, 2020 / 12:48 PM / 16 days ago

BRIEF-Zai Lab Announces Acceptance Of NDA Submission Of Omadacycline In China By The Nmpa

Zai Lab Ltd:

* ZAI LAB ANNOUNCES ACCEPTANCE OF NDA SUBMISSION OF OMADACYCLINE IN CHINA BY THE NMPA

* ZAI LAB LTD - OMADACYCLINE FILING WITH NMPA WAS ACCEPTED AS A CATEGORY 1 DRUG & WILL BE LOCALLY MANUFACTURED IN CHINA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below